MCF7/TAMR-1 Cell Line Product
MCF7/TAMR-1 cell line is a stable tamoxifen-resistant subline. This cell line has been established in tissue culture after long term treatment with 1 uM tamoxifen. Tamoxifen (Nolvadex) is a […]
MCF7/TAMR-1 cell line is a stable tamoxifen-resistant subline. This cell line has been established in tissue culture after long term treatment with 1 uM tamoxifen. Tamoxifen (Nolvadex) is a […]
The MCF7/TAMR-7 Cell line is a breast cancer cell line resistant to tamoxifen. The MCF7/TAMR-7 cell line is a good model cell to study the signalling pathways, which are the […]
The MCF7/S0.5 cell line has been established to grow at low serum. the MCF-7/S0.5 cell line has been adapted to long-term growth at 0.5 % fetal bovine serum in order […]
The MCF7/S9 cell line was established to grow in serum free medium to enable studies of the effect of estrogens and antiestrogens under conditions without influence of estrogenic compounds supplied […]
MCF7/AnaR-1 is a cell culture model mimicking acquired resistance of aromatase inhibitors (AIs) – an anti-cancer therapy. This breast cancer cell line was established from MCF7/S0.5 cells, which originates […]
MCF7/AnaR-2 is a cell culture model mimicking acquired resistance of aromatase inhibitors (AIs) – an anti-cancer therapy. This breast cancer cell line was established from MCF7/S0.5 cells, which originates […]
MCF7/AnaR-4 is a cell culture model mimicking acquired resistance of aromatase inhibitors (AIs) – an anti-cancer therapy. This breast cancer cell line was established from MCF7/S0.5 cells, which originates […]
The MCF7/164R-4 cell line is a breast cancer cell line resistant to fulvestrant (Faslodex). The MCF7/164R-4 cell line is a human breast cancer cell line established from MCF7. The cellular […]
The MCF7/ExeR-4 Cell Line was developed as a model of resistance to anti-cancer treatment with aromatase inhibitors.
The MCF7/ExeR-2 Cell Line was developed as a model of resistance to anti-cancer treatment with aromatase inhibitors.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.